Clinical Study of LILRA6 CAR-T for the Treatment of R/R Acute Myeloid Leukemia

NCT07263906 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Refractory Acute Myeloid Leukemia
Recurrent Acute Myeloid Leukemia

Interventions

BIOLOGICAL: Anti-LILRA6 CAR-T cells

Sponsor

Second Affiliated Hospital, School of Medicine, Zhejiang University